The cancer registry software market size in Europe is estimated to be worth USD 34.71 million by 2028 from USD 22.17 million in 2023, growing at a CAGR of 9.38% from 2023 to 2028.
The rising prevalence of cancer diseases among the European population primarily drives the European cancer registry software market. As per the statistics published by Eurostat, an estimated 2.7 million new cancer cases were recorded in Europe in 2020 and the incidence of cancer is much more likely to accelerate in the coming years in Europe. Factors such as lifestyle changes, hormonal imbalances and genetic predisposition contribute to the incidence of cancer. The increasing death rate among cancer patients further fuels the demand for cancer registry software and contributes to regional market growth. Cancer registries are software systems designed to collect, store and manage data on individuals with cancer, play a crucial role in cancer surveillance and reducing the burden of the disease. Additionally, these registries support research efforts conducted by various cancer-related organizations.
The rising demand for quality care for cancer and the increasing importance of cost reduction in healthcare boosts the growth rate of the European cancer registry software market. Healthcare providers and researchers utilize data from cancer registries to optimize healthcare costs. Valuable solutions have been derived from the analysis of registry data and enable more efficient and cost-effective care delivery, which is contributing to the regional market growth.
The growing number of advancements in software development for the efficient use of cancer registries fuels the growth rate of the European market. Software developers are dedicated to creating innovative solutions with advanced features, incorporating technologies such as big data and machine learning to enhance efficiency. The focus on research and development, along with the approval of software solutions, receives substantial investment from both the public and private sectors further contributing to the market's growth.
The growing number of approvals and rapid adoption of software solutions in the healthcare industry, initiatives and regulations from the European governments to promote the use of cancer registry software, growing awareness about the benefits of cancer registry software in improving patient outcomes, integration of cancer registry software with electronic health record (EHR) systems and rising emphasis on data-driven decision-making and evidence-based practices in cancer treatment further fuel the growth rate of the European cancer registry software market.
Limited adoption of electronic health records (EHR) systems in some healthcare facilities and concerns regarding data security and patient privacy majorly inhibit the cancer registry software market growth in Europe. The lack of standardized data collection and reporting processes across different healthcare systems and limited financial resources for implementing and maintaining cancer registry software further inhibit the regional market. Resistance to change and reluctance to adopt new technologies among healthcare providers is another major roadblock to European market growth.
This research report on the Europe cancer registry software market has been segmented and sub-segmented into the following categories.
By Software:
By Deployment Model:
By Component:
By End Use:
By Functionality:
By Country:
Europe was one of the dominating regional markets for cancer registry software worldwide in 2022 and is expected to account for a notable share of the global market during the forecast period. The UK led the cancer registry software market in Europe in 2022 and is anticipated to witness a healthy CAGR during the forecast period owing to the increasing number of government initiatives and increased awareness of cancer diagnosis and treatment. Cancer welfare organizations and healthcare entities conduct awareness campaigns to educate individuals about the importance of registering their data in cancer hospitals. The European Network of Cancer Registries conducts comprehensive programs to collect extensive data and provide training for cancer registry personnel. The establishment of numerous cancer clinics and specialized hospitals and collaborations between cancer clinicians and healthcare providers to provide improved patient outcomes further drive the UK market growth.
Germany held a considerable share of the European market in 2022 and is forecasted to grow at a promising CAGR during the forecast period due to the growing number of startup companies and the widespread adoption of electronic health records in hospitals. Electronic health records capture crucial patient information, including personal details, disease history, medication, and treatment. Cancer registry software utilizes this data from electronic healthcare records to analyze cancer statistics and support preventive measures.
KEY MARKET PARTICIPANTS:
Elekta AB, C/NET Solutions, Onco, Inc., Rocky Mountain Cancer Data Systems and Iatric Systems, Inc. are some of the major companies in the European cancer registry software market
Frequently Asked Questions
The Europe cancer registry software market size is projected to reach USD 34.71 Million by 2028.
The growth rate of the Europe cancer registry software market is 9.38% during the forecast period.
Elekta AB, C/NET Solutions, Onco, Inc., Rocky Mountain Cancer Data Systems and Iatric Systems, Inc. are some of the key market players in the Europe next-generation antibody therapeutics market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region